Study Explores Masimo PVi® for Targeted Liquid Therapy in Elderly Surgical Patients

Researchers found that fluid therapy guided by non-invasive and continuous PVi can reduce cardiopulmonary complications and infusion.   Masimo (NASD...

August 22, 2023 | Tuesday | News
AGC Biologics Partners with Asahi Kasei Pharma Corporation on Clinical Antibody Project

Under the agreement, AGC Biologics will leverage its monoclonal antibody development and manufacturing experience to perform process transfer, process opti...

August 17, 2023 | Thursday | News
TAE Life Sciences Partners with Biddle Sawyer for Cancer Treatment Drug

TAE Life Sciences has  announced a landmark agreement with Biddle Sawyer to serve as the exclusive supplier of TC220, a novel boronated amino aci...

August 16, 2023 | Wednesday | News
MediWound Announces Collaboration with Mölnlycke on EscharEx® Phase III Study

MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today anno...

August 16, 2023 | Wednesday | News
Hong Kong Department of Health has Approved the Registration Applications for the Uro-G and Uro-V Disposable Cystoscopic System

Uro-G offers a viewing angle of 120°, both 210° upward and 130° downward motion angles, and a 90° angle of rotation clockwise and countercl...

August 15, 2023 | Tuesday | News
Pfizer's ELREXFIO™ Granted U.S. FDA Accelerated Approval for Refractory Multiple Myeloma

The approval of ELREXFIO (elranatamab-bcmm) is based on clinically meaningful response rates and duration of response from Phase 2 MagnetisMM-3 study EL...

August 15, 2023 | Tuesday | News
Bristol Myers Squibb Joins Billion Dollar Roundtable, Boosts Supplier Diversity

- Achieves $1 billion investment goal with diverse-owned suppliers Expanding diverse-owned supplier spend globally to increase impact BMS established...

August 11, 2023 | Friday | News
Lilly Completes Acquisition of DICE Therapeutics

"Since our founding nearly 150 years ago, we've strived to make life better for people around the world – but we know that to achieve this goal, we h...

August 10, 2023 | Thursday | News
Astellas Invests in Poseida Therapeutics to Redefine Cancer Cell Therapy

Poseida is a clinical-stage biotechnology company dedicated to advancing a new class of cancer cell therapy and gene therapy products using genetic enginee...

August 08, 2023 | Tuesday | News
Within3 Enhances Insights Platform, Cuts Workload by 90%

Within3 announced a major step forward in delivering business impact through artificial intelligence (AI) in the drug commercialization arena. The com...

August 02, 2023 | Wednesday | News
China's NMPA Accepts Astellas' Zolbetuximab Biologics License Application

Moitreyee Chatterjee-Kishore, PhD, MBA, Senior Vice President and Head of Immuno-Oncology Development, Astellas"China accounts for nearly half of...

August 01, 2023 | Tuesday | News
EmVenio Research & TrialHub Partner to Boost Clinical Trial Efficiency

Through TrialHub's data intelligence gathering platform, EmVenio can easily identify optimal markets to attract clinical trial participants who are needed ...

July 28, 2023 | Friday | News
Everest Medicines Announces Commercial Launch and First Prescription for XERAVA® in China

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization ...

July 27, 2023 | Thursday | News
Bharat Serums and Vaccines Initiates Compliance Measures for Assisted Reproduction Methods

India based biopharmaceutical firm Bharat Serums and Vaccines has roped in Bureau Veritas (India) Pvt. Ltd. (BVIL), a world leader in Audit and Certificati...

July 26, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close